NCT05741450

Brief Summary

The study objective was to gather short-term clinical performance data for two soft contact lenses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 24, 2022

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 5, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 5, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 14, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 23, 2023

Completed
11 months until next milestone

Results Posted

Study results publicly available

January 10, 2024

Completed
Last Updated

January 10, 2024

Status Verified

February 1, 2023

Enrollment Period

11 days

First QC Date

February 14, 2023

Results QC Date

November 28, 2023

Last Update Submit

December 18, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Subjective Overall Score

    Subjective overall score was assessed using 0-100 visual analogue scale, where 0=Extremely poor, cannot use lenses and 100=Excellent, highly impressed with these lenses overall

    15 minutes

Secondary Outcomes (2)

  • Subjective Comfort

    15 minutes

  • Subjective Vision

    15 minutes

Study Arms (2)

Lens 1

EXPERIMENTAL

All participants wore Lens 1 for 15 minutes (Period 1)

Device: Lens 1 (monthly replacement)

Lens 2

EXPERIMENTAL

All participants wore Lens 2 for 15 minutes (Period 2)

Device: Lens 2 (daily disposable)

Interventions

Monthly replacement spherical silicone hydrogel contact lens for 15 minutes

Lens 1

Daily disposable spherical silicone hydrogel contact lens for 15 minutes

Lens 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • They are of legal age (18) and capacity to volunteer.
  • They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent.
  • They are willing and able to follow the protocol.
  • They currently wear soft contact lenses, or have done so within the past two years.
  • They are expected to be able to be fitted with the study lenses within the power range available.

You may not qualify if:

  • They have an ocular disorder which would normally contra-indicate contact lens wear.
  • They have a systemic disorder which would normally contra-indicate contact lens wear.
  • They are using any topical medication such as eye drops or ointment.
  • They are aphakic.
  • They have had corneal refractive surgery.
  • They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
  • They are pregnant or lactating.
  • They have an eye or health condition including an immunosuppressive or infectious disease which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or a history of anaphylaxis or severe allergic reaction.
  • They have taken part in any contact lens or care system clinical research within two weeks prior to starting this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eurolens Research

Manchester, United Kingdom

Location

MeSH Terms

Conditions

MyopiaHyperopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
José A. Vega OD, MSc, FAAO
Organization
CooperVision, Inc.

Study Officials

  • Philip Morgan, PhD, MCOptom

    Eurolens Research

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: All participants received Lens 1 and then Lens 2 in fixed-sequence order.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 14, 2023

First Posted

February 23, 2023

Study Start

November 24, 2022

Primary Completion

December 5, 2022

Study Completion

December 5, 2022

Last Updated

January 10, 2024

Results First Posted

January 10, 2024

Record last verified: 2023-02

Locations